Desidustat Tablets are novel, oral HIF-PHI for treating anaemia in non-dialysis adult chronic kidney disease patients. The Product is administrated orally, thus expecting to...
In a recent study published in Communications Materials, scientists reviewed current research on using wearable breath sensors to monitor respiratory parameters such as temperature,...
New York NY, March 19, 2024– (Plato Data) - In the realm of pharmaceutical innovation,
XORTX Therapeutics Inc. (NASDAQ: XRTX | TSXV: XRTX | Frankfurt:...
SCD-PED (Pediatric) is the first FDA-approved product in the Company’s Quelimmune™ product family
DENVER, Feb. 22, 2024 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq:...
Medtech startup Samphire Neuroscience secured €2.1 million in pre-seed funding to launch Nettle, their medical-grade neurostimulation wearable. The round saw contributions from notable venture...
Home > Press > First human trial shows ‘wonder’ material can be developed safely: A revolutionary nanomaterial with huge potential to tackle multiple...
By: Juan Sebastian Chaves GilYou've likely heard or read about the preparation of marijuana juice, sparking your curiosity to give it a try. Therefore,...
A preventative anti-aging therapy seems like wishful thinking.Yet a new study led by Dr. Corina Amor Vegas at Cold Spring Harbor Laboratory describes a...
DENVER, Feb. 01, 2024 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a medical device company developing proprietary solutions to reduce the consequences...
